BUZZ-Australia's Singular Health hits two-month high on FDA clearance for medical imaging tech
Reuters
Jan 13
BUZZ-Australia's Singular Health hits two-month high on FDA clearance for medical imaging tech
** Shares of Australia's Singular Health GroupSHG.AX rise as much as 15.4% to A$0.30, their highest level November 13
** The biotech co says the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for 3DICOM MD® Cloud, which is a cloud evolution of co's FDA approved medical imaging device
** 3DICOM MD® Cloud has been cleared as a Class II Software as a Medical Device, enabling marketing and clinical use of the platform in the United States, co says
** Stock gained 13.3% in 2025, and is up 7.8% YTD
(Reporting by Shruti Agarwal in Bengaluru)
((Shruti.Agarwal@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.